Stoke Therapeutics Inc. (STOK) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Stoke Therapeutics Inc.

    NASDAQ: STOK · Real-Time Price · USD
    25.56
    0.74 (2.98%)
    At close: Oct 03, 2025, 3:59 PM
    25.95
    1.53%
    After-hours: Oct 03, 2025, 07:40 PM EDT

    Stoke Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 36.55M 8.78M 12.4M n/a
    Cost of Revenue
    		 n/a 4.73M 3.54M 2.23M
    Gross Profit
    		 36.55M 8.78M 12.4M -2.23M
    Operating Income
    		 -101.37M -114.77M -104.36M -86.06M
    Interest Income
    		 12.64M 9.91M 3.12M 120K
    Pretax Income
    		 -88.98M -104.7M -101.07M -85.81M
    Net Income
    		 -88.98M -104.7M -101.07M -85.81M
    Selling & General & Admin
    		 48.79M 41.32M 38.92M 31.9M
    Research & Development
    		 89.13M 82.23M 77.84M 54.17M
    Other Expenses
    		 n/a n/a n/a -2.23M
    Operating Expenses
    		 137.93M 123.55M 116.76M 83.83M
    Interest Expense
    		 n/a n/a n/a 120K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 137.93M 123.55M 116.76M 86.06M
    Income Tax Expense
    		 n/a n/a -7.96M -1.09M
    Shares Outstanding (Basic)
    		 54.01M 43.99M 38.9M 36.74M
    Shares Outstanding (Diluted)
    		 54.01M 43.99M 38.9M 36.74M
    EPS (Basic)
    		 -1.65 -2.38 -2.6 -2.34
    EPS (Diluted)
    		 -1.65 -2.38 -2.6 -2.34
    EBITDA
    		 -99.19M -112.3M -102.81M -83.58M
    EBIT
    		 -101.37M -114.77M -104.36M -85.81M
    Depreciation & Amortization
    		 2.18M 2.47M 1.55M 2.23M

    Add to Watchlist